Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Late Stage Gastrointestinal Cancer”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Active Not RecruitingNCT03252938
What this trial is testing

Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

Who this might be right for
Solid TumorsPeritoneal CarcinomatosisNSCLC Adenocarcinoma+1 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 83
Testing effectiveness (Phase 2)UnknownNCT05095636
What this trial is testing

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Gastric CancerMetastasis
Fudan University 102
Not applicableUnknownNCT05427227
What this trial is testing

Prospectively Predict the Efficacy and Explore the Mechanism of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy

Who this might be right for
Advanced or Late Stage Gastrointestinal Cancer
Peking University 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287
What this trial is testing

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Who this might be right for
Metastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more
National Cancer Institute (NCI) 57
Not applicableUnknownNCT05879328
What this trial is testing

The ImmunoXXL Study

Who this might be right for
Hepatocellular Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 12
Early research (Phase 1)Ended earlyNCT05494866
What this trial is testing

A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
CYP3A InhibitorAdvanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Cancer+2 more
German Cancer Research Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07467590
What this trial is testing

Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study

Who this might be right for
Refractory Colorectal CancerRadiotherapy-Induced Immune PrimingImmune Response
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 33
Not applicableStudy completedNCT02786524
What this trial is testing

Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

Who this might be right for
Uterine Cervical NeoplasmsOvarian NeoplasmsGynecologic Neoplasms+4 more
University of Michigan 107
Large-scale testing (Phase 3)Study completedNCT00109954
What this trial is testing

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 120
Testing effectiveness (Phase 2)UnknownNCT05395780
What this trial is testing

Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Maxinovel Pty., Ltd. 30
Not applicableStudy completedNCT04496765
What this trial is testing

Early-onset Rectal Cancer

Who this might be right for
Rectal Cancer
Mansoura University 244
Testing effectiveness (Phase 2)Study completedNCT03925870
What this trial is testing

KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 45
Very early researchLooking for participantsNCT04601428
What this trial is testing

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center 43
Early research (Phase 1)UnknownNCT05675462
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Early research (Phase 1)UnknownNCT06010901
What this trial is testing

A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 75
Large-scale testing (Phase 3)Active Not RecruitingNCT06346392
What this trial is testing

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 592
Testing effectiveness (Phase 2)Active Not RecruitingNCT07143604
What this trial is testing

Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 33
Testing effectiveness (Phase 2)UnknownNCT01993784
What this trial is testing

Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Cancer
Peking University 9
Early research (Phase 1)Study completedNCT00999882
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

Who this might be right for
CancerAdvanced Hepatocellular Carcinoma
AstraZeneca 26